Keytruda (pembrolizumab) is a prescription drug that’s used to treat certain forms of cancer. Keytruda comes as an intravenous (IV) infusion (an injection into your vein given over time ...

Merck (NYSE:MRK) announced Wednesday that the U.S. Food and Drug Administration (FDA) approved a label expansion for its blockbuster therapy Keytruda to allow its use as a first-line combination ...

Merck & Co's KEYNOTE-158 trial of Keytruda has underpinned another FDA ... to superstar status and the risks associated with its off-label use. In the age of AI, large data sets – like the ...

Merck & Co/MSD has won approval in the US for PD-1 inhibitor Keytruda as a treatment for hepatocellular ... The FDA approval is based on the results of the open-label KEYNOTE-224 trial, which ...

It is an eviscerating label. “Wimp” does not begin to convey it. Female, Saudi, and fierceLong discouraged from sports, especially those that clerics call masculine, urban women are drawn to ...

The king of Saudi Arabia has issued a decree allowing women to drive, bringing to an end the country's dubious distinction as the only place on earth banning the practice. But even when that ...

Among patients with early triple-negative breast cancer, treatment with Keytruda (pembrolizumab) demonstrated real-world evidence of immune-related adverse effects (irAEs) comparable with KEYNOTE-522, ...

The study KEYFORM-007 tested Keytruda with monoclonal antibody therapy favezelimab as a late-line option in patients with ...

KEYNOTE-689 trial showed significant improvement in event-free survival for stage 3 or 4A resected head and neck squamous cell carcinoma with Keytruda. Keytruda regimen included neoadjuvant therapy, ...

Saudi Arabia has an oil-based economy with strong government controls over major economic activities. It possesses about 16% of the world's proven petroleum reserves, ranks as the largest exporter ...

KEYTRUDA plus chemotherapy is the first approval in the EU for an anti-PD-1 therapy combined with chemotherapy only for patients with primary advanced or recurrent endometrial carcinoma regardless ...